272 related articles for article (PubMed ID: 9660544)
1. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
Viale M; Pastrone I; Pellecchia C; Vannozzi MO; Cafaggi S; Esposito M
Anticancer Drugs; 1998 Jun; 9(5):457-63. PubMed ID: 9660544
[TBL] [Abstract][Full Text] [Related]
2. Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388 leukemic cells in vitro and in vivo.
Pastrone I; Viale M; Cafaggi S; Mariggiò MA; Parodi A; Esposito M
Invest New Drugs; 1998-1999; 16(4):297-302. PubMed ID: 10426661
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
Viale M; Cafaggi S; Parodi B; Esposito M
Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
[TBL] [Abstract][Full Text] [Related]
4. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the toxicities of cisplatin and a new cisplatin-procaine complex to rat renal cortical slices.
Zhang JG; Esposito M; Cafaggi S; Lindup WE
Hum Exp Toxicol; 1996 Jan; 15(1):59-63. PubMed ID: 8845212
[TBL] [Abstract][Full Text] [Related]
6. Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR.
Viale M; Minetti S; Ottone M; Lerza R; Parodi B; Pannacciulli I
Anticancer Drugs; 2003 Feb; 14(2):163-6. PubMed ID: 12569303
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate.
Mariggiò MA; Cafaggi S; Ottone M; Parodi B; Vannozzi MO; Mandys V; Viale M
Invest New Drugs; 2004 Jan; 22(1):3-16. PubMed ID: 14707490
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin combined with the new cisplatin-procaine complex DPR: in vitro and in vivo studies.
Viale M; Vannozzi MO; Merlo F; Cafaggi S; Parodi B; Esposito M
Eur J Cancer; 1996 Dec; 32A(13):2327-33. PubMed ID: 9038617
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.
Kaufmann SH; Peereboom D; Buckwalter CA; Svingen PA; Grochow LB; Donehower RC; Rowinsky EK
J Natl Cancer Inst; 1996 Jun; 88(11):734-41. PubMed ID: 8637027
[TBL] [Abstract][Full Text] [Related]
10. Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice.
Ognio E; Lapide M; Ottone M; Mandys V; Peterka M; Parodi B; Viale M
Arch Toxicol; 2003 Oct; 77(10):584-90. PubMed ID: 14574446
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic effect of cisplatin and the cisplatin-procaine complex DPR studied in organotypic cultures of chick embryonic dorsal root ganglia.
Mandys V; Viale M; Vrana J; Cafaggi S; Esposito M
Anticancer Drugs; 1998 Aug; 9(7):659-63. PubMed ID: 9773811
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.
Poindessous V; Koeppel F; Raymond E; Cvitkovic E; Waters SJ; Larsen AK
Int J Oncol; 2003 Nov; 23(5):1347-55. PubMed ID: 14532976
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride.
Cafaggi S; Esposito M; Parodi B; Vannozzi MO; Viale M; Pellecchia C; Fulco RA; Merlo F; Zicca A; Cadoni A
Anticancer Res; 1992; 12(6B):2285-92. PubMed ID: 1295476
[TBL] [Abstract][Full Text] [Related]
14. [Chemosensitivity test for 170 human breast carcinoma samples].
He Z; Yuan J; Chen Z; Liu S; Shen Z; Fei H
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):531-4. PubMed ID: 10806759
[TBL] [Abstract][Full Text] [Related]
15. Embryotoxicity of cisplatin and a cisplatin-procaine complex (DPR) studied in chick embryo.
Peterka M; Mandys V; Viale M; Cafaggi S; Peterková R; Esposito M
Neoplasma; 2002; 49(6):394-400. PubMed ID: 12584587
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
[TBL] [Abstract][Full Text] [Related]
18. [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Geng M; Yin YC; Cao YC; Fu ZJ; Wang XY; Tai YH
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):838-41. PubMed ID: 18396642
[TBL] [Abstract][Full Text] [Related]
19. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
[TBL] [Abstract][Full Text] [Related]
20. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]